EFTA01523011

GHISLAINE MAXWELL-HY ACCT. For the Period 1/1/13 to 1/31/13 Pike Quantity Value Adjusted Tax Cost Unreakzed Gain/Loss Est. Annua) Income `acid Original Cost Acaved Interest US FINCd Income DAVITA INC 107.25 10,000.00 10,725.00 10,200.00 525.00 637.50 4.91% 63/8% NOV 01 2018 159.37 DTD 10/20/2010 23918K-AL-2 NR /82 TEMET HEALTHCARE CORP 110.00 5,000.00 5,500.00 5,400.00 100.00 312.50 4.27% 6.25% NOV01 2018 78.12 Dit 11/21/2011 88033G-BP-4 B« /B1 CSC HOLDINGS LLC 121.47 10.000.00 12,146.60 11,425.00 721.60 862.50 4.52% 85/8% FEB 15 2019 397.70 DIM 02/12/2009 126307-AC-1 BB+ /BA3 HCA INC 111.75 20 000 00 22,350.00 22,250 00 100.00 1,700.00 6.19% 812% APR 15 2019 500.54 Dit 04/15/2010 404119-BF-5 BB /BA3 FELCOR LODGING LP 107.50 5,000.00 5.375.00 5,057.50 317.50 337.50 5.34% 63/4% JUN 01 2019 56.25 DTD 05/10/2011 31430Q-BB-2 B- /NR ARCELORIVaTrAL 125.79 6,000.00 7.547.52 6.922.50 625.02 591.00 5.04% 9.85% JUN 01 2019 98.49 DTD 05202009 039381.-AM6 BB+ /BAI CINEMARK USA INC 111.61 10.000.00 11,160.70 11.205.00 (44.30) 862.50 6.38% 8 5/8% JUN 15 2019 110.20 DTD 12/15/2009 172441-AS-6 8B- /132 J.P.Morgan Page 11 of 25 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00050610 SDNY_GM_00319808 EFTA01523011